• 1
    Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 2000; 287: 257081.
  • 2
    Koenig W, Rosenson RS. Acute-phase reactants and coronary heart disease. Semin Vasc Med 2002; 2: 41728.DOI: 10.1055/s-2002-36770
  • 3
    Lowe GDO, Rumley A, Whincup PH, Danesh J. Hemostatic and rheological variables and risk of cardiovascular disease. Semin Vasc Med 2002; 2: 42940.DOI: 10.1055/s-2002-36771
  • 4
    Fibrinogen Studies Collaboration. Collaborative meta-analysis of prospective observational studies of plasma fibrinogen and cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2004; 11: 917.
  • 5
    Danesh J, Wheeler JG, Hirshfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 138797.DOI: 10.1056/NEJMoa032804
  • 6
    Lowe GDO, Danesh J, Lewington S, Walker M, Lennon L, Thomson A, Rumley A, Whincup PH. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 2004; 25: 2529.DOI: 10.1016/j.ehj.2003.11.004
  • 7
    Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GDO. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1999; 104: 24657.DOI: 10.1046/j.1365-2141.1999.01158.x
  • 8
    Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent. Diabetes Care 1999; 22 (Suppl. 3): C25C30.
  • 9
    Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. A randomised trial. JAMA 2003; 289: 1799804.DOI: 10.1001/jama.289.14.1799
  • 10
    Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 1998; 21: 64954.
  • 11
    Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000; 102: 427.
  • 12
    Frohlich M, Koenig W, Imhof A, Hutchinson BG, Pepys MB, Boeing H, Muche R, Brenner H. Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care 2000; 23: 18359.
  • 13
    Meigs JB, Mittelman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheeky PM, Lipinska I, D'Agostino RB, Wilson PWF. Hyperinsulinaemia, hyperglycemia, and impaired hemostasis. The Framingham Offspring Study. JAMA 2000; 283: 2218.DOI: 10.1001/jama.283.2.221
  • 14
    Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000; 152: 897907.DOI: 10.1093/aje/152.10.897
  • 15
    Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leucocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003; 168: 3518.DOI: 10.1016/S0021-9150(03)00134-5
  • 16
    Marques-Vidal P, Mazoye E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrieres J. Prevalence of insulin resistance syndrome in Southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 2003; 25: 13717.
  • 17
    Wannamethee SG, Lowe GDO, Rumley A, Lennon L, Whincup PH. The metabolic syndrome and insulin resistance and their relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis 2005; (in press).
  • 18
    Juhan-Vague I, Alessi MC, Mavri A, Morange PE. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 2003; 1: 15759.DOI: 10.1046/j.1538-7836.2003.00279.x
  • 19
    Wannamethee SG, Lowe GDO, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 178590.
  • 20
    Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, Whincup PH. Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in type 2 diabetic men with and without coronary heart disease. Diabetologia 2004; 47: 155765.DOI: 10.1007/s00125-004-1491-7